The U.S. Food and Drug Administration approved treatment for 11 patients with the rare familial ALS caused by mutations in ...

Xcellbio announced today that it had granted bluebird bio, Inc., a commercial license and entered into a supply agreement for the use of Xcellbio’s proprietary cell manufacturing technology, AVATAR™, ...

The French Connection’ legend and his children were in regular contact before his death and he made sure they were adequately ...

Provides update on the Company’s transformation and promising portfolio of innovative gene therapy treatments for inherited retinal ...

Navitas Semiconductor's revenue grew 5% 2024. The stock price declined in response, and is now near a record low. See why I ...